Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Carpenter

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Psychiatry|August 19, 2009
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illnessDawn I Velligan, Peter J Weiden, Martha Sajatovic, et al.
Journal of Psychiatric Practice|September 23, 2010
Strategies for addressing adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelinesDawn I Velligan, Peter J Weiden, Martha Sajatovic, et al.
Journal of General Internal Medicine|October 2, 2024
Vaccine Messaging by the FDA: A National Randomized Survey StudyWilliam B Feldman, Leah Z Rand, Daniel Carpenter, et al.
Journal of Psychiatric Practice|January 26, 2010
Assessment of adherence problems in patients with serious and persistent mental illness: recommendations from the Expert Consensus GuidelinesDawn I Velligan, Peter J Weiden, Martha Sajatovic, et al.
The Western Journal of Emergency Medicine|November 24, 2015
The Impact of Medical Student Participation in Emergency Medicine Patient Care on Departmental Press Ganey ScoresAaron W Bernard, Daniel R Martin, Mark G Moseley, et al.
JMIR Research Protocols|August 20, 2024
Evaluating the Efficacy of a Digital Therapeutic (CT-152) as an Adjunct to Antidepressant Treatment in Adults With Major Depressive Disorder: Protocol for the MIRAI Remote StudyBrian Rothman, Mary Slomkowski, Austin Speier, et al.
Clinical Pharmacology and Therapeutics|May 17, 2024
Trust in the Food and Drug Administration: A National Survey StudyWilliam B Feldman, Leah Z Rand, Daniel Carpenter, et al.
Journal of Affective Disorders|May 16, 2025
A digital therapeutic (CT-152) as adjunct to antidepressant medication: A phase 3 randomized controlled trial (the Mirai study)Brian Rothman, Mary Slomkowski, Austin Speier, et al.
Medical Care|May 15, 2012
Warnings without guidance: patient responses to an FDA warning about ezetimibeWilliam H Shrank, Niteesh K Choudhry, Angela Tong, et al.
Lancet (London, England)|May 20, 2015
Global health security: the wider lessons from the west African Ebola virus disease epidemicDavid L Heymann, Lincoln Chen, Keizo Takemi, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Psychiatry|August 19, 2009
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illnessDawn I Velligan, Peter J Weiden, Martha Sajatovic, et al.
Journal of Psychiatric Practice|September 23, 2010
Strategies for addressing adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelinesDawn I Velligan, Peter J Weiden, Martha Sajatovic, et al.
Journal of General Internal Medicine|October 2, 2024
Vaccine Messaging by the FDA: A National Randomized Survey StudyWilliam B Feldman, Leah Z Rand, Daniel Carpenter, et al.
Journal of Psychiatric Practice|January 26, 2010
Assessment of adherence problems in patients with serious and persistent mental illness: recommendations from the Expert Consensus GuidelinesDawn I Velligan, Peter J Weiden, Martha Sajatovic, et al.
The Western Journal of Emergency Medicine|November 24, 2015
The Impact of Medical Student Participation in Emergency Medicine Patient Care on Departmental Press Ganey ScoresAaron W Bernard, Daniel R Martin, Mark G Moseley, et al.
JMIR Research Protocols|August 20, 2024
Evaluating the Efficacy of a Digital Therapeutic (CT-152) as an Adjunct to Antidepressant Treatment in Adults With Major Depressive Disorder: Protocol for the MIRAI Remote StudyBrian Rothman, Mary Slomkowski, Austin Speier, et al.
Clinical Pharmacology and Therapeutics|May 17, 2024
Trust in the Food and Drug Administration: A National Survey StudyWilliam B Feldman, Leah Z Rand, Daniel Carpenter, et al.
Journal of Affective Disorders|May 16, 2025
A digital therapeutic (CT-152) as adjunct to antidepressant medication: A phase 3 randomized controlled trial (the Mirai study)Brian Rothman, Mary Slomkowski, Austin Speier, et al.
Medical Care|May 15, 2012
Warnings without guidance: patient responses to an FDA warning about ezetimibeWilliam H Shrank, Niteesh K Choudhry, Angela Tong, et al.
Lancet (London, England)|May 20, 2015
Global health security: the wider lessons from the west African Ebola virus disease epidemicDavid L Heymann, Lincoln Chen, Keizo Takemi, et al.
Pageof 7